Evidence supporting the use of: Vitamin E (delta tocotrienol)
For the body system: Hepatic System

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Delta tocotrienol, a member of the vitamin E family, has received increasing scientific attention for its potential hepatoprotective (liver-protecting) effects. Unlike tocopherols, tocotrienols—especially the delta and gamma isomers—exhibit unique biological activities. Several preclinical studies in animal models have demonstrated that delta tocotrienol can reduce hepatic steatosis (fatty liver), oxidative stress, and inflammation, all of which are central to liver injury and the progression of non-alcoholic fatty liver disease (NAFLD). Mechanistically, delta tocotrienol has been shown to modulate lipid metabolism, inhibit inflammatory pathways such as NF-κB, and enhance antioxidant defenses within hepatic cells. A limited number of human clinical trials support these findings. For example, small-scale studies have shown that supplementation with tocotrienol-rich fractions can improve liver enzyme profiles and reduce markers of oxidative stress in patients with NAFLD. However, these trials often use mixed tocotrienols and not isolated delta tocotrienol, so direct evidence specific to the delta isomer remains relatively scarce. Overall, while there is promising preclinical and emerging clinical evidence supporting the use of delta tocotrienol for hepatic health, the evidence base is not yet robust or large-scale. Therefore, its use is scientifically justified, but the level of evidence is moderate and more high-quality human studies are needed to confirm its efficacy and safety for liver support.

More about Vitamin E (delta tocotrienol)
More about Hepatic System

Products containing Vitamin E (delta tocotrienol)

We currently have no products on Vitabase that contain this ingredient.